• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CRISPR

The Top Line
Podcast

Biopharma briefing: Q1 trends, gene therapy news, ASCO preview

In this episode of "The Top Line," we break down first-quarter Big Pharma earnings, recap gene therapy developments and preview what’s ahead at ASCO.
Ayla Ellison , Eric Sagonowsky , Kevin Dunleavy , Gabrielle Masson , Darren Incorvaia May 30, 2025 9:46am
photo of a green light on a stoplight

NICE signs off on Vertex, CRISPR's Casgevy for beta thalassemia

Aug 7, 2024 8:20pm
Biovectra manufacturing

Agilent will pay $925M to acquire specialty CDMO Biovectra

Jul 22, 2024 11:01am
partnership collaboration legal document

Michigan Medicaid signs deal with bluebird for SCD gene therapy

Mar 11, 2024 11:00am
The Top Line

'The Top Line': Gene editing's next act

Feb 16, 2024 8:55am
Vertex

Vertex's sales of Trikafta hit $8.9B thanks to label expansion

Feb 6, 2024 12:39pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings